BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17969271)

  • 1. [Validation of an ELISA assay for the quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide].
    Toraño Peraza G; Hernández Vadell I; Baly A; Toledo Romaní ME
    Rev Cubana Med Trop; 2005; 57(3):185-91. PubMed ID: 17969271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
    Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
    Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.
    Mawas F; Bolgiano B; Rigsby P; Crane D; Belgrave D; Corbel MJ
    Biologicals; 2007 Oct; 35(4):235-45. PubMed ID: 17337205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and vaccine-induced immunity against Haemophilus influenzae type b in patients with beta-thalassemia.
    Spoulou VI; Tsoumas DL; Ladis V; Spentzou A; Theodoridou MC
    Vaccine; 2006 Apr; 24(16):3050-3. PubMed ID: 16519975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
    Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibody response to polysaccharides in children with recurrent respiratory tract infections.
    López-Yap A; Abdelnour A; Lomonte B; Porras O
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):1012-4. PubMed ID: 11527819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of functional Haemophilus influenzae type b antibodies after vaccination.
    van der Velden AM; Claessen AM; van Velzen-Blad H; Biesma DH; Rijker GT
    Haematologica; 2005 Nov; 90(11):1582-4. PubMed ID: 16266910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda.
    Muganga N; Uwimana J; Fidele N; Gahimbare L; Gessner BD; Mueller JE; Mhlanga BR; Katsande R; Herbinger KH; Rugambwa C
    Vaccine; 2007 Sep; 25(39-40):7001-5. PubMed ID: 17709159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the immune response to combination vaccines.
    Ball LK; Falk LA; Horne AD; Finn TM
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S299-305. PubMed ID: 11709763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b capsular polysaccharide detection and measurement by an enzyme-linked immunosorbent assay (ELISA).
    Tiller FW; Diener E
    Zentralbl Bakteriol A; 1981 Feb; 248(4):488-93. PubMed ID: 7013364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of murine monoclonal antibodies to Haemophilus influenzae type b capsular polysaccharide by in vivo immunization.
    Kodituwakku AP; Zola H; Roberton DM
    Hybrid Hybridomics; 2004 Jun; 23(3):160-7. PubMed ID: 15312306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative study on saccharide quantification of the
    Rosskopf U; Daas A; Terao E; von Hunolstein C
    Pharmeur Bio Sci Notes; 2017; 2017():44-68. PubMed ID: 29017702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.
    Ravi G; Venkatesh YP
    Glycoconj J; 2014 Nov; 31(8):573-85. PubMed ID: 25108762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycobiology. Synthetic vaccine is a sweet victory for Cuban science.
    Kaiser J
    Science; 2004 Jul; 305(5683):460. PubMed ID: 15273367
    [No Abstract]   [Full Text] [Related]  

  • 17. The human B-lymphocyte response to Haemophilus influenzae type b capsular polysaccharide coupled to protein.
    Barington T
    APMIS Suppl; 1995; 56():1-40. PubMed ID: 8546878
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.
    Gessner BD
    Expert Rev Vaccines; 2009 Jan; 8(1):91-102. PubMed ID: 19093776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
    Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
    Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.